Elevated PIVKA-II is Associated with Early Recurrence and Poor Prognosis in BCLC 0-A Hepatocellular Carcinomas |
Wang, Bei-Li
(Department of Laboratory Medicine, Zhongshan Hospital, Fudan University)
Tan, Qi-Wen (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University) Gao, Xing-Hui (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University) Wu, Jiong (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University) Guo, Wei (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University) |
1 | Bertino G, Ardiri A, Malaguarnera M, et al (2012). Hepatocellualar carcinoma serum markers. Semin Oncol, 39, 410-33. DOI |
2 | Bruix J, Sherman M (2011). Management of hepatocellular carcinoma: an update. Hepatology, 53, 1020-2. DOI ScienceOn |
3 | Cai XY, Wang JX, Yi Y, et al (2014). Low counts of T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection. Asian Pac J Cancer Prev, 15, 775-80. DOI |
4 | Cha C, Fong Y, Jarnagin WR, et al (2003). Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg, 197, 753-8. DOI ScienceOn |
5 | Chan SL, Mo FK, Johnson PJ, et al (2009). New utility of an old marker: serial-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. J Clin Oncol, 27, 446-52. |
6 | Gupta SP, Mittal A, Sathian B, et al (2013). Elevated serum insulin is an independent risk factor for hepatocellular carcinoma: a case control study from Nepal. Asian Pac J Cancer Prev, 14, 7331-3. 과학기술학회마을 DOI |
7 | Kang SH, Kim do Y, Jeon SM, et al (2012). Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. Eur J Gastroenterol Hepatol, 24, 849-56. DOI |
8 | Kim JM, Hyuck C, Kwon D, et al (2013). Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma. World J Surg, 37, 1371-8. DOI |
9 | Li N, Hu WJ, Shi J, et al (2013). Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 3509-14. 과학기술학회마을 DOI |
10 | Lovet JM, Bru C, Bruix J (1999). Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 19, 329-38. DOI ScienceOn |
11 | Matsubara M, Shiraha H, Kataoka J, et al (2012). Des--carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma. J Gastroenterol Hepatol, 27, 1602-8. DOI |
12 | Shah SA, Greig PD, Gallinger S, et al (2006). Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg, 202, 275-83. DOI ScienceOn |
13 | Mittal A, Gupta SP, Sathian B, et al (2012). Des-gammacarboxyprothrombin for early identification and prognosis of hepatocellular carcinoma: a case control study from western Nepal. Asian Pac J Cancer Prev, 13, 5773-5. 과학기술학회마을 DOI |
14 | Park H, Park JY (2013). Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma. Biomed Res Int, 310427. |
15 | Santi V, Trevisani F, Gramenzi A, et al (2010). Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol, 53, 291-7. DOI ScienceOn |
16 | Shah SA, Cleary SP, Wei AC, et al (2007). Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery, 141, 330-9. DOI ScienceOn |
17 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
18 | Takayama T, Makuuchi M, Kojiro M, et al (2008). Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol, 15, 972-8. DOI |
19 | Tung-Ping Poon R, Fan ST, Wong J (2000). Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg, 232, 10-24. DOI ScienceOn |
20 | Wang SB, Cheng YN, Cui SX, et al (2009a). Des-gammacarboxy prothrombin stimulates human vascular endothelial cell growth and migration. Clin Exp Metastasis, 26, 469-77. DOI |
21 | Shi L, Wu LL, Yang JR, et al (2014). Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patients. Asian Pac J Cancer Prev, 15, 2979-86. 과학기술학회마을 DOI |
22 | Wang CC, Iyer SG, Low JK, et al (2009b). Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol, 16, 1832-42. DOI ScienceOn |
23 | Wang NY, Wang C, Li W, et al (2014). Prognostic value of serum AFP, AFP-L3, and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation. Asian Pac J Cancer Prev, 15, 1539-44. 과학기술학회마을 DOI ScienceOn |
24 | Yamamoto K, Imamura H, Matsuyama Y, et al (2010). AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol, 45, 1272-82. DOI |
25 | Kim do Y, Paik YH, Ahn SH, et al (2007). PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology, 72, 52-7. DOI |